CLINICAL AND EPIDEMIOLIGICAL FEATURES OF COMPLEX DISEASES IN SELF TREATMENT

Tuychiyev Sardor Azamatovich, Karshi State University, Faculty of Medicine e-mail:tuychiyev_9292@gmail.ru

Авторы

  • Tuychiyev Sardor Azamatovich

Аннотация

Diseases of osteoporosis and the assessment of the patient is taken
from the degree of fracture as a marker of many diseases. But bone mineral density
(SMZ) is also associated with disease and the risk of fracture. Metabolic disorders
associated with secondary osteoporosis are 2-3 times higher in women and in men with
hip fractures and vertebral fractures. Globally, osteoporosis is the most common
metabolic, bone disease, affecting more than 200 million people worldwide. In Europe,
the United States and Japan, 75 million people are diagnosed with osteoporosis. As
SMZ decreases, osteoporosis increases with age. Senile osteoporosis is more common
in people over 70 years of age. Secondary osteoporosis can occur in any person.
Although bone loss in women begins gradually, it accelerates menopause, with
delivery at age 50 and beyond. The incidence of postmenopausal osteoporosis is
highest in 50-70 women. Women are higher on osteoporosis. Half of postmenopausal
women have fractures associated with life and osteoporosis; Ush develops a spinal
deformity in 25% of women, and 15% experience hip fractures. Hip fractures are
similar in different ethnicities.

Библиографические ссылки

Clinical rheumatology: a guide to practice. doctors; Yakovlev G.P St. Petersburg: Folio, 2001. - 416 p.

Mendel O.I., Naumov A.V., Alekseeva L.I. Osteoarthritis as a risk factor for cardiovascular activity // Rus. medical jurnali - 2007. - T. 15, 23-son. - Pages 1-5.

Mitrofanov V.A. Osteoarthritis: risk factors, pathogenesis and modern // Saratov scientific-med. Journal - 2008. - Issue 2. - S. 23-30.

Starodubtseva I.A., Nikitin A.V., Barsukova N.A. Evaluation of the effectiveness of Diaflex in patients with primary and secondary osteoarthritis // 6th Congress of Russian Rheumatologists: Lectures. - M., 2013. - P.151.

Garnero P. Biochemical symptoms of osteoarthritis // Osteoarthritis: accompanying the publication "Rheumatology". L. Sharma, F. Berenbaum. 2012. - P. 113-128.

Alekseyeva L.I., Sharapova E.P. Combination drugs in the treatment of osteoarthritis // Journal of Medical Consultation - 2012.

Drozdov V.N., Kim V.A. Diagnosis and treatment of osteoarthritis., 2010. 23 p.

Kazimirko V.K., Kovalenko V.N., Maltsev V.I. Primary (age-related, involutional) osteoarthritis. 2006. - 176 p.

Karateev A.E. Treatment of osteoarthritis in terms of pharmacotherapy safety // 2009. 18 p.

Kotelnikov G.P., Lartsev Yu.V. Osteoarthritis. - M: GEOTAR-Media, 2009.

Опубликован

2022-08-24